DK3284816T3 - Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme - Google Patents

Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme Download PDF

Info

Publication number
DK3284816T3
DK3284816T3 DK16780164.6T DK16780164T DK3284816T3 DK 3284816 T3 DK3284816 T3 DK 3284816T3 DK 16780164 T DK16780164 T DK 16780164T DK 3284816 T3 DK3284816 T3 DK 3284816T3
Authority
DK
Denmark
Prior art keywords
cultiving
tissue
cells
same
addition
Prior art date
Application number
DK16780164.6T
Other languages
English (en)
Inventor
Natsuki Abe
Taito Nishino
Ayako Otani
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Application granted granted Critical
Publication of DK3284816T3 publication Critical patent/DK3284816T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/12—Agar or agar-agar, i.e. mixture of agarose and agaropectin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/12—Agar-agar; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK16780164.6T 2015-04-16 2016-04-15 Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme DK3284816T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015084590 2015-04-16
JP2015229974 2015-11-25
PCT/JP2016/062689 WO2016167373A1 (ja) 2015-04-16 2016-04-15 培地添加物及び培地組成物並びにそれらを用いた細胞又は組織の培養方法

Publications (1)

Publication Number Publication Date
DK3284816T3 true DK3284816T3 (da) 2022-06-13

Family

ID=57126592

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16780164.6T DK3284816T3 (da) 2015-04-16 2016-04-15 Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme

Country Status (8)

Country Link
US (1) US10914725B2 (da)
EP (1) EP3284816B1 (da)
JP (2) JPWO2016167373A1 (da)
KR (1) KR20170137149A (da)
CN (1) CN107532143A (da)
DK (1) DK3284816T3 (da)
TW (1) TWI713516B (da)
WO (1) WO2016167373A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014017513A1 (ja) * 2012-07-24 2014-01-30 日産化学工業株式会社 培地組成物及び当該組成物を用いた細胞又は組織の培養方法
CN105769909A (zh) * 2016-05-13 2016-07-20 云南舜喜再生医学工程有限公司 一种直接获得富含细胞因子血清的采血器及方法
JP7049164B2 (ja) * 2017-04-25 2022-04-06 栄研化学株式会社 微生物培養用の寒天培地
WO2019009425A1 (ja) * 2017-07-07 2019-01-10 日産化学株式会社 造腫瘍性の評価方法
US11252954B2 (en) 2017-09-08 2022-02-22 Nissan Chemical Corporation Method for preserving a cell material in an unfrozen state
CN108998441A (zh) * 2018-08-02 2018-12-14 南方医科大学深圳医院 一种三维肿瘤球培养基添加剂、培养基以及三维肿瘤球培养方法
KR102230614B1 (ko) * 2018-11-13 2021-03-22 한국화학연구원 세포 배양용 캐리어를 이용하여 제조된 오가노이드 및 이를 이용한 약물 독성 평가방법
US20220162561A1 (en) 2019-04-04 2022-05-26 Nissan Chemical Corporation Composition for promoting secretion of extracellular vesicles
JP7344016B2 (ja) * 2019-06-17 2023-09-13 国立大学法人 東京大学 培養方法
WO2022004846A1 (ja) 2020-07-03 2022-01-06 国立大学法人 岡山大学 軟骨組織体の製造方法
JP7426316B2 (ja) * 2020-09-16 2024-02-01 日清食品ホールディングス株式会社 メチルセルローススラリー及びその製造方法並びに該メチルセルローススラリーを含む肉様蛋白加工食品及びその製造方法
CN112980689A (zh) * 2021-02-08 2021-06-18 湖南美柏生物医药有限公司 一种贴壁细胞的培养装置、2.5d蜂箱式培养体系及方法
CN114561341B (zh) * 2022-04-02 2024-04-26 东南大学 一种基于iPSC的三维胰岛类器官及其构建方法
CN115161256B (zh) * 2022-06-20 2024-03-12 广州远想生物科技股份有限公司 一种虎杖悬浮细胞、其外泌体及其制备方法和应用
CN116731219A (zh) * 2023-06-13 2023-09-12 嘉保生物科技(保山)有限公司 一种改性低酰基透明型结冷胶及制备方法与在微生物培养基中的应用
CN117126799B (zh) * 2023-10-26 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种三维肺上皮细胞聚集体及其作为肺炎症模型的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779772A (ja) 1993-09-13 1995-03-28 W R Grace & Co 細胞培養液及びその培養液を用いたスフェロイドの製造方法
GB0026473D0 (en) * 2000-10-30 2000-12-13 Unilever Plc Shear gel compositions
JP4220756B2 (ja) * 2002-10-28 2009-02-04 極東製薬工業株式会社 培養器、培養器の製造方法及び培養方法
JP4263513B2 (ja) * 2003-03-20 2009-05-13 三栄源エフ・エフ・アイ株式会社 咀嚼・嚥下困難者用食品ならびに咀嚼・嚥下補助組成物
JP2009229339A (ja) * 2008-03-25 2009-10-08 National Institute Of Information & Communication Technology 顕微鏡観察用サンプル作製方法、及びそれに用いるキット
US9125839B2 (en) 2010-03-12 2015-09-08 The Nisshin Oillio Group, Ltd. Composition for external use on skin, cosmetic, and cleaning agent
CN103732737A (zh) * 2011-03-24 2014-04-16 怀特黑德生物制剂研究所 用于培养来自正常人输卵管卵巢上皮和人输卵管卵巢肿瘤的细胞的组合物和方法
WO2013051590A1 (ja) * 2011-10-03 2013-04-11 国立大学法人鹿児島大学 水溶性ホルマザンを生成するテトラゾリウムを用いた定量的軟寒天コロニー形成アッセイ
US9664671B2 (en) * 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
WO2014017513A1 (ja) 2012-07-24 2014-01-30 日産化学工業株式会社 培地組成物及び当該組成物を用いた細胞又は組織の培養方法
JP6074799B2 (ja) * 2012-10-10 2017-02-08 伊那食品工業株式会社 乳酸菌増殖促進剤及びこれを含有するヨーグルト

Also Published As

Publication number Publication date
JP7452519B2 (ja) 2024-03-19
TW201643245A (zh) 2016-12-16
KR20170137149A (ko) 2017-12-12
TWI713516B (zh) 2020-12-21
JP2022025134A (ja) 2022-02-09
US10914725B2 (en) 2021-02-09
EP3284816A4 (en) 2018-11-14
WO2016167373A1 (ja) 2016-10-20
CN107532143A (zh) 2018-01-02
EP3284816A1 (en) 2018-02-21
JPWO2016167373A1 (ja) 2018-02-08
US20180136196A1 (en) 2018-05-17
EP3284816B1 (en) 2022-03-16

Similar Documents

Publication Publication Date Title
DK3284816T3 (da) Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme
DK3460042T3 (da) Celledyrkningsmedium til dyrkning af et organoid, dyrkningsfremgnagsmåde og organoid
DK3207124T3 (da) Fremgangsmåder og sammensætninger til generering eller bevaring af pluripotente celler
DK4026917T5 (da) Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse
DK3782639T3 (da) Sammensætninger og fremgangsmåder til internalisering af enzymer
EP3418376A4 (en) CELL CULTURE MEDIUM, CULTURE METHOD AND ORGANOID
DK3294325T5 (da) Forbedring af virkningen af car-manipulerede t-celler ved hjælp af nukleinsyrevaccination
DK3500664T3 (da) Fremgangsmåde til differentiering af pluripotente celler
DK3207130T3 (da) Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
DK3155101T3 (da) Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren
DK3114225T3 (da) Sammensætning og fremgangsmåde til stabilisering af nukleinsyrer i biologiske prøver
EP3138399A4 (en) Composition for organ, tissue, or cell transplantation, kit, and transplantation method
DK3471733T3 (da) Reagenser, sammensætninger og fremgangsmåder til forbedring af cellers, vævs og organers levedygtighed og funktion
DK3607050T3 (da) Ex vivo-dyrkningssystem og metoder til brugen af samme
DK3242957T3 (da) Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
DK3606929T3 (da) Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme
DK3500661T3 (da) Cellekulturindsats og anordning til kultivering af celler
BR112018010676A2 (pt) polipeptídeo termoestável, uso e meio de cultura
DK3331986T3 (da) Fremgangsmåde til fremstilling af celledyrkningsmedium
DK3397748T3 (da) Fremgangsmåde til dyrkning og konservering af Eubacterium hallii
DK3325606T3 (da) Biomasse fra thraustochytrider beriget med olier og proteiner, dyrkningsfremgangsmåde og anvendelser
EP3375863A4 (en) CELL CULTURE METHOD USING A MEDIUM CONTAINING A LAMININ FRAGMENT
EP3641840A4 (en) SCAFFOLDING FOR CELL CULTURE AND TISSUE REGENERATION
DK3390364T3 (da) Små molekyler til hæmning af kemokinaktivitet og/eller cancercellevækst
DK3270686T3 (da) Fremstilling af ingenol, ingenolestere og/eller tiglian-3-on-derivater ved hjælp af Euphorbiaceae-plantecellesuspensions-kulturer